Loading company…
Tortugas Neuroscience develops therapies for neurological and neuropsychiatric conditions.
Founded in 2024 by Jeff Jonas and Albert Robichaud, Tortugas Neuroscience is based in Framingham, US. Its pipeline includes TRTL-107, TRTL-913, TRTL-729 and TRTL-118 for brain disorders. In April 2026, Cure Ventures, The Column Group and AN Ventures Partners co-led its Series A round, part of a larger USD 106 million seed and Series A funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in